Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Medications for PCOS don't seem to raise heart disease risk.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

N6-methyladenosine affects hair follicle development differently in Rex and Hycole rabbits.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Both estrogens and androgens are important for health in both males and females.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Activin B helps start and grow hair follicles in mice.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.